Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonafexor and Entecavir Interaction Study
NCT03469583Phase 1Completed
- Sponsor
- ENYO Pharma
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of vonafexor in Chronic Hepatitis B (CHB) (3 arms), sponsored by ENYO Pharma. Primary endpoint: Area Under the Curve at 24 hours. Started Feb 2018; status: completed.
02
Drugs
vonafexor
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT03469583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469583.